Ingliforib(CAS: 186392-65-4)

Ingliforib (CAS: 186392-65-4) is subject to regulations such as GHS classification, REACH under the European Union, and FDA/EPA requirements. Specific guidelines include safety data sheets (SDS), material safety data sheets (MSDS), and environmental release criteria.

Alternatives to Ingliforib in synthesis include similar compounds with analogous structures or isomers. Common alternatives might involve substituting Ingliforib with reagents like 5-Fluorouracil or analogs such as uracil derivatives, depending on the specific chemical reaction requirements.

The market trend for Ingliforib (CAS: 186392-65-4) indicates increasing research interest, particularly in its applications in pharmaceuticals and biotechnology. Recent studies focus on its potential as a therapeutic agent, with a growing number of clinical trials exploring its efficacy in cancer treatments and other diseases.

Waste containing Ingliforib (CAS: 186392-65-4) should be collected in appropriate containers and stored separately. Proper incineration or professional waste disposal services should be utilized. Environmental protection precautions include ensuring that disposal methods comply with local and international regulations to minimize environmental impact.